首页> 外文期刊>International Journal of Pharmaceutics >Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
【24h】

Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.

机译:壳聚糖原位凝胶化可改善泊洛沙姆407凝胶中的载药量和保留率。

获取原文
获取原文并翻译 | 示例
           

摘要

A method for the in situ gelation of poloxamers and the mucoadhesive polymer chitosan has been developed by exploiting the tendency of poloxamer solution to form gel at physiological temperatures and of chitosan (CT) to form ionotropic gel structures in the presence of sodium tripolyphosphate (TPP). Novel poloxamer gels containing CT-TPP complex formed in situ during the administration were prepared by mixing poloxamer-CT and poloxamer-TPP solutions in double syringes. The micellization and gelation of poloxamer 407 in the presence of chitosan and/or TPP were studied using differential scanning calorimetry and tube inversion; both additives were found to reduce the critical micellization temperature and critical gelation temperature of poloxamer aqueous solution. The poloxamer gels containing CT-TPP complex formed in situ were found to exhibit reduced dissolution rate and superior release characteristics with three different drugs--metoprolol, doxycycline and flufenamic acid. Furthermore, by varying the compositions of the two solutions independently, it is possible to control the pH in a way to suit the solubilization of a drug as well as the specific environment of a particular application site. By varying the concentrations of chitosan, TPP and poloxamer, the delivery system can be fine-tuned to afford gels with specific properties, ranging from nanoparticle suspensions to semisolid gels. These in situ gels have the potential to increase the utility of thermo-reversible poloxamers in drug delivery.
机译:通过利用泊洛沙姆溶液在生理温度下形成凝胶的趋势以及在三聚磷酸钠(TPP)存在下壳聚糖(CT)形成离子型凝胶结构的趋势,已经开发出一种泊洛沙姆和粘膜粘附性聚合物壳聚糖原位凝胶化的方法。 。通过在双注射器中混合泊洛沙姆-CT和泊洛沙姆-TPP溶液来制备在给药过程中原位形成的含有CT-TPP复合物的新型泊洛沙姆凝胶。使用差示扫描量热法和试管倒置法研究了在壳聚糖和/或TPP存在下泊洛沙姆407的胶束化和胶凝作用。发现两种添加剂均可以降低泊洛沙姆水溶液的临界胶束化温度和临界胶凝温度。发现含有原位形成的CT-TPP配合物的泊洛沙姆凝胶显示出降低的溶出速率和优异的释放特性,这三种药物是美托洛尔,强力霉素和氟苯那酸。此外,通过独立地改变两种溶液的组成,可以以适合药物溶解以及特定应用部位的特定环境的方式控制pH。通过改变壳聚糖,TPP和泊洛沙姆的浓度,可以微调输送系统,以提供具有特定性质的凝胶,从纳米颗粒悬浮液到半固体凝胶。这些原位凝胶具有增加热可逆泊洛沙姆在药物递送中的效用的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号